Lumos Diagnostics Holdings Limited LDXHF
0.06 USD +0.01 (+20.00%)
Regular-session close
0.0756 Day range 0.0756
0.04 52-week range 0.24
- YTD
- -70.63%
- 1 year
- -60.00%
News
seekingalpha.com Lumos Diagnostics Holdings Limited (LDXHF) Shareholder/Analyst Call Transcript Lumos Diagnostics Holdings Limited (LDXHF) Shareholder/Analyst Call Transcript
seekingalpha.com Lumos Diagnostics Holdings Limited (LDXHF) Q1 2027 Earnings Call Transcript Lumos Diagnostics Holdings Limited (LDXHF) Q1 2027 Earnings Call Transcript
proactiveinvestors.com Lumos Diagnostics to provide US FebriDx update at quarterly results briefing Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) will provide a US commercial update on FebriDx at an investor briefing on October 27, following the planned release of its September-quarter…
proactiveinvestors.com Lumos Diagnostics appoints Tenmile Ventures representative to board as US commercialisation advances Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has appointed healthcare investment specialist Aizaz Syed as a non-executive director, strengthening its board with representation from its largest…
proactiveinvestors.com Nvidia Q2 earnings beat expectations with strong data center growth Nvidia Corp (NASDAQ:NVDA, XETRA:NVD) forecast third-quarter revenue above Wall Street estimates on Wednesday, extending a run of blowout results driven by...
proactiveinvestors.com FTSE 100 Live: Next and Glencore provide results boost, SpaceX tumbles FTSE 100 up 19 points to 10,899 Oil prices waver as Hormuz deal mooted SpaceX's earnings beat runs into a $116bn problem Next, Glencore, Legal & General,...
proactiveinvestors.com Tower Semiconductor tops second quarter earnings and revenue expectations Tower Semiconductor (NASDAQ:TSEM) has reported second quarter results above Wall Street expectations, including record revenue and profitability as the...
proactiveinvestors.com Lumos Diagnostics secures US$768,000 FebriDx order as US commercial rollout gathers pace Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has received a US$767,800 purchase order for its FebriDx® rapid diagnostic test from US distribution...
proactiveinvestors.com Small Cap watch: Pantoro hits spectacular gold and Lumos secures US order The S&P/ASX Small Ordinaries continued its positive run, rising 26.6 points, or 0.8%, to close yesterday at 3,341.2. The small-cap benchmark has now gained...
proactiveinvestors.com Starbucks Q3 profit beats on US turnaround, lifts full-year guidance Starbucks Corp (NASDAQ:SBUX, XETRA:SRB) beat Wall Street estimates for fiscal third-quarter revenue and profit as its turnaround plan drove...
proactiveinvestors.com Shell plans £3.1bn of buybacks as profits soar on higher oil prices Shell PLC (LSE:SHEL, NYSE:SHEL) shares rose after stronger oil and gas prices and improved trading led to its highest profits since 2022, with $4.2 billion...
seekingalpha.com Lumos Diagnostics Holdings Limited (LDXHF) Q4 2026 Earnings Call Transcript Lumos Diagnostics Holdings Limited (LDXHF) Q4 2026 Earnings Call Transcript
proactiveinvestors.com Cameco gets UBS upgrade on strengthening uranium bull case Cameco Corporation (TSX:CCO) has been upgraded to Buy by UBS on a strengthened uranium bull case that analysts believe is not reflected in the producer's...
proactiveinvestors.com Lumos Diagnostics caps FY26 with FebriDx revenue up 875% and US rollout gaining momentum Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) finished the fourth quarter of FY26 with strong full-year growth from its flagship FebriDx® rapid...
proactiveinvestors.com FTSE 100 Live: Stocks advance as oil price retreats, China's new chip champion IPOs FTSE 100 up 40 points at 10,777 Oil prices drop as US and Iran pause strikes AstraZeneca and Vodafone report as results season ups a gear 10.19am: Have you...
proactiveinvestors.com Nasdaq jumps as tech stocks revive, GM and 3M deliver earnings beats 11:00am: AI rally faces reality Some analysts are wondering whether market expectations have already been pushed too high. Linh Tran, Market Analyst at...
proactiveinvestors.com Dow Jones closes above 52,000 for the first time as US-Iran truce holds 4:15pm: New record close for the Dow US stocks were boosted on Monday by easing geopolitical tensions and a Supreme Court ruling that backed the Fed’s...
proactiveinvestors.com Lumos Diagnostics receives A$710,000 R&D tax rebate to support point-of-care technology development Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) has received a A$709,837 cash refund under the Australian Government’s Research and Development Tax...
seekingalpha.com Lumos Diagnostics Holdings Limited (LDXHF) Discusses Commercialisation Update and Market Strategy for FebriDx in the U.S. Transcript Lumos Diagnostics Holdings Limited (LDXHF) Discusses Commercialisation Update and Market Strategy for FebriDx in the U.S. Transcript
proactiveinvestors.com US commercialisation of FebriDx® to be discussed at Lumos Webinar: Thursday, June 11, at 10:30am AEST Lumos Diagnostics Holdings Ltd (ASX:LDX, OTC:LDXHF) will host a virtual investor briefing on Thursday, June 11, at 10:30am AEST to provide an update on the...
